| dc.contributor.author | Öztürk, Ahmet | |
| dc.contributor.author | Çelik, Şükrü | |
| dc.contributor.author | Kodaz, Hilmi | |
| dc.contributor.author | Yıldız, İbrahim | |
| dc.contributor.author | Ocak, Ayşe | |
| dc.contributor.author | Hacıbekiroğlu, İlhan | |
| dc.contributor.author | Bayoğlu, İbrahim Vedat | |
| dc.contributor.author | Ercelep, Özlem | |
| dc.contributor.author | Avcı, Nilüfer | |
| dc.date.accessioned | 2019-06-13T11:43:41Z | |
| dc.date.available | 2019-06-13T11:43:41Z | |
| dc.date.issued | 2018 | en_US |
| dc.identifier.issn | 1556-0864 | |
| dc.identifier.issn | 1556-1380 | |
| dc.identifier.uri | https://doi.org/10.1016/j.jtho.2018.08.1593 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12462/5446 | |
| dc.description | Avcı, Nilüfer (Balikesir Author) | en_US |
| dc.description.abstract | There have been important developments in NSCLC since the understanding of molecular pathways. The aim of the study is to find the EGFR mutation frequency and its correlation to survival and clinicopathological features. We reported our data in this subject three years ago. We aim to resubmit our updated data. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Elsevier Science | en_US |
| dc.relation.isversionof | 10.1016/j.jtho.2018.08.1593 | en_US |
| dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
| dc.subject | EGFR Mutation | en_US |
| dc.subject | NSCLC | en_US |
| dc.subject | Treatment | en_US |
| dc.title | EGFR mutation in patients with NSCLC and its relationship between survival and clinicopathological features: an update analysis | en_US |
| dc.type | conferenceObject | en_US |
| dc.relation.journal | Journal Of Thoracic Oncology | en_US |
| dc.contributor.department | Tıp Fakültesi | en_US |
| dc.identifier.volume | 13 | en_US |
| dc.identifier.issue | 10 | en_US |
| dc.identifier.startpage | S880 | en_US |
| dc.identifier.endpage | S880 | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
